Aatmaj Healthcare Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aatmaj Healthcare Ltd is ₹ 22.8 as of 23 Oct 15:30 . The P/E Ratio of Aatmaj Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Aatmaj Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Aatmaj Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of Aatmaj Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of Aatmaj Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Aatmaj Healthcare Ltd changed from 12.84 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Aatmaj Healthcare Ltd

Aatmaj Healthcare Limited was originally incorporated under the name Aatmaj Healthcare Private Limited' on March 10, 2014 issued by the RoC, Gujarat.
Thereafter, the Company was converted to Public Limited Company and name of the Company was changed to Aatmaj Healthcare Limited' vide fresh Certificate of Incorporation dated December 06, 2022.
The Company is a rapidly growing organization to establish itself as a leading healthcare provider, utilizing modern medicinal practices and advanced infrastructure for medical and surgical care solutions. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services.
The main activities of the Company include operation of multidisciplinary private hospitals and clinics.
The healthcare facilities consist of advanced technology and doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Aatmaj Healthcare Ltd and Syngene International Ltd

Which company has a larger market capitalization, Aatmaj Healthcare Ltd or Syngene International Ltd?

Market cap of Aatmaj Healthcare Ltd is 51 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of Aatmaj Healthcare Ltd and Syngene International Ltd?

The stock performance of Aatmaj Healthcare Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aatmaj Healthcare Ltd and Syngene International Ltd?

As of October 25, 2026, the Aatmaj Healthcare Ltd stock price is INR ₹22.8. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of Aatmaj Healthcare Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Aatmaj Healthcare Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.